E-MAIL UPDATES

Click here to join

At the cutting edge

At the
cutting edge.

Research for life

Research
for life.

Innovation and performance

Innovation and
performance.

Latest

What's new.

October 4th 2022
analyst reports

This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional investors) in the applicable jurisdiction, and not by any private individuals or other persons who qualify as retail clients.

September 15th 2022
analyst reports

Upcoming Events

What's next.

November 8th 2022 - November 10th 2022

read more
November 15th 2022 - November 17th 2022

read more

Who we are

About us.

passion.

It takes a great deal of passion to pursue the fight against cancer and autoimmune diseases. We put our heart and soul into winning it.

know-how.

Our goal is to gather the strongest forces, the brightest minds and the most dedicated employees.

research.

Accurate research and development is the strongest foundation for developing effective treatments.

What is LAG-3?
Lymphocyte-activation gene 3, or LAG-3 (LAG-3), is a gene that provides the genetic information to make a cell surface molecule with biologic effects on T cell function.
LAG-3 is being used for many immunotherapy treatments including Eftilagimod Alpha from Immutep.